A 0 1 0 1 O
patient 2 9 2 9 O
with 10 14 10 14 O
an 15 17 15 17 O
intracerebral 18 31 18 31 B-chronic_disease
hemorrhage 32 42 32 42 I-chronic_disease

Acute 0 5 43 48 O
bleeding 6 14 49 57 O
associated 15 25 58 68 O
with 26 30 69 73 O
a 31 32 74 75 O
fall 33 37 76 80 O
in 38 40 81 83 O
hemoglobin 41 51 84 94 B-clinical_variable
level 52 57 95 100 I-clinical_variable
by 58 60 101 103 O
≥2 61 63 104 106 O
g 64 65 107 108 I-lower_bound
/ 65 66 108 109 I-lower_bound
dL 66 68 109 111 I-lower_bound

Acute 0 5 112 117 B-chronic_disease
bleeding 6 14 118 126 I-chronic_disease
associated 15 25 127 137 O
with 26 30 138 142 O
a 31 32 143 144 O
hemoglobin 33 43 145 155 B-clinical_variable
level 44 49 156 161 I-clinical_variable
of 50 52 162 164 O
≤8 53 55 165 167 O
g 56 57 168 169 I-upper_bound
/ 57 58 169 170 I-upper_bound
dL 58 60 170 172 I-upper_bound
if 61 63 173 175 O
no 64 66 176 178 O
baseline 67 75 179 187 O
hemoglobin 76 86 188 198 O
is 87 89 199 201 O
available 90 99 202 211 O

Acute 0 5 212 217 B-chronic_disease
bleeding 6 14 218 226 I-chronic_disease
in 15 17 227 229 O
a 18 19 230 231 O
critical 20 28 232 240 O
area 29 33 241 245 O
or 34 36 246 248 O
organ 37 42 249 254 O
such 43 47 255 259 O
as 48 50 260 262 O
intraspinal 51 62 263 274 O
, 62 63 274 275 O
pericardial 64 75 276 287 O
, 75 76 287 288 O
or 77 79 289 291 O
intracranial 80 92 292 304 O

Acute 0 5 305 310 B-chronic_disease
bleeding 6 14 311 319 I-chronic_disease
that 15 19 320 324 O
is 20 22 325 327 O
potentially 23 34 328 339 O
life 35 39 340 344 O
- 39 40 344 345 O
threatening 40 51 345 356 O

Dabigatran 0 10 357 367 B-treatment

Expected 0 8 368 376 O
survival 9 17 377 385 O
of 18 20 386 388 O
less 21 25 389 393 O
than 26 30 394 398 O
1 31 32 399 400 B-upper_bound
month 33 38 401 406 I-upper_bound

For 0 3 407 410 O
patients 4 12 411 419 O
with 13 17 420 424 O
intracranial 18 30 425 437 B-chronic_disease
bleeding 31 39 438 446 I-chronic_disease
, 39 40 446 447 O
there 41 46 448 453 O
must 47 51 454 458 O
be 52 54 459 461 O
a 55 56 462 463 O
reasonable 57 67 464 474 O
expectation 68 79 475 486 O
that 80 84 487 491 O
andexanet 85 94 492 501 B-treatment
treatment 95 104 502 511 I-treatment
will 105 109 512 516 O
commence 110 118 517 525 O
within 119 125 526 532 O
2 126 127 533 534 B-upper_bound
hours 128 133 535 540 I-upper_bound
of 134 136 541 543 O
the 137 140 544 547 O
baseline 141 149 548 556 O
imaging 150 157 557 564 O
evaluation 158 168 565 575 O

Glasgow 0 7 576 583 B-clinical_variable
coma 8 12 584 588 I-clinical_variable
score 13 18 589 594 I-clinical_variable
< 19 20 595 596 O
7 21 22 597 598 B-upper_bound

Intracerebral 0 13 599 612 B-clinical_variable
hematoma 14 22 613 621 I-clinical_variable
> 23 24 622 623 O
60 25 27 624 626 B-lower_bound
cc 28 30 627 629 I-lower_bound
as 31 33 630 632 O
assessed 34 42 633 641 O
by 43 45 642 644 O
CT 46 48 645 647 O
or 49 51 648 650 O
MRI 52 55 651 654 O

Patient 0 7 655 662 O
has 8 11 663 666 O
received 12 20 667 675 O
any 21 24 676 679 O
of 25 27 680 682 O
the 28 31 683 686 O
following 32 41 687 696 O
drugs 42 47 697 702 B-treatment
or 48 50 703 705 I-treatment
blood 51 56 706 711 I-treatment
products 57 65 712 720 I-treatment
within 66 72 721 727 O
7 73 74 728 729 B-upper_bound
days 75 79 730 734 I-upper_bound
of 80 82 735 737 O
Screening 83 92 738 747 O

Patient 0 7 748 755 O
received 8 16 756 764 O
or 17 19 765 767 O
is 20 22 768 770 O
believed 23 31 771 779 O
to 32 34 780 782 O
have 35 39 783 787 O
received 40 48 788 796 O
one 49 52 797 800 O
of 53 55 801 803 O
the 56 59 804 807 O
following 60 69 808 817 O
within 70 76 818 824 O
18 77 79 825 827 B-upper_bound
hours 80 85 828 833 I-upper_bound
prior 86 91 834 839 I-upper_bound
to 92 94 840 842 O
andexanet 95 104 843 852 B-treatment
administration 105 119 853 867 O
: 119 120 867 868 O
apixaban 121 129 869 877 B-treatment
, 129 130 877 878 O
rivaroxaban 131 142 879 890 B-treatment
, 142 143 890 891 O
edoxaban 144 152 892 900 B-treatment
or 153 155 901 903 O
enoxaparin 156 166 904 914 B-treatment

Planned 0 7 915 922 O
administration 8 22 923 937 O
of 23 25 938 940 O
PCC 26 29 941 944 B-treatment
, 29 30 944 945 O
fresh 31 36 946 951 B-treatment
frozen 37 43 952 958 I-treatment
plasma 44 50 959 965 I-treatment
( 51 52 966 967 I-treatment
FFP 52 55 967 970 I-treatment
) 55 56 970 971 I-treatment
or 57 59 972 974 O
rfVIIa 60 66 975 981 B-treatment
from 67 71 982 986 O
Screening 72 81 987 996 O
until 82 87 997 1002 O
within 88 94 1003 1009 O
12 95 97 1010 1012 B-upper_bound
hours 98 103 1013 1018 I-upper_bound
after 104 109 1019 1024 O
the 110 113 1025 1028 O
end 114 117 1029 1032 O
of 118 120 1033 1035 O
the 121 124 1036 1039 O
andexanet 125 134 1040 1049 B-treatment
infusion 135 143 1050 1058 I-treatment

Pregnant 0 8 1059 1067 B-pregnancy

Prothrombin 0 11 1068 1079 B-treatment
Complex 12 19 1080 1087 I-treatment
Concentrate 20 31 1088 1099 I-treatment
products 32 40 1100 1108 I-treatment
( 41 42 1109 1110 I-treatment
PCC 42 45 1110 1113 I-treatment
) 45 46 1113 1114 I-treatment
or 47 49 1115 1117 O
recombinant 50 61 1118 1129 B-treatment
factor 62 68 1130 1136 I-treatment
VIIa 69 73 1137 1141 I-treatment
( 74 75 1142 1143 I-treatment
rfVIIa 75 81 1143 1149 I-treatment
) 81 82 1149 1150 I-treatment

Recent 0 6 1151 1157 O
history 7 14 1158 1165 O
( 15 16 1166 1167 O
within 16 22 1167 1173 O
2 23 24 1174 1175 B-upper_bound
weeks 25 30 1176 1181 I-upper_bound
) 30 31 1181 1182 O
of 32 34 1183 1185 O
a 35 36 1186 1187 O
diagnosed 37 46 1188 1197 O
thrombotic 47 57 1198 1208 O
event 58 63 1209 1214 O
( 64 65 1215 1216 O
TE 65 67 1216 1218 O
) 67 68 1218 1219 O

Severe 0 6 1220 1226 B-chronic_disease
sepsis 7 13 1227 1233 I-chronic_disease
or 14 16 1234 1236 O
septic 17 23 1237 1243 B-chronic_disease
shock 24 29 1244 1249 I-chronic_disease
at 30 32 1250 1252 O
the 33 36 1253 1256 O
time 37 41 1257 1261 O
of 42 44 1262 1264 O
Screening 45 54 1265 1274 O

The 0 3 1275 1278 O
patient 4 11 1279 1286 O
is 12 14 1287 1289 O
scheduled 15 24 1290 1299 O
to 25 27 1300 1302 O
undergo 28 35 1303 1310 O
surgery 36 43 1311 1318 B-treatment
in 44 46 1319 1321 O
less 47 51 1322 1326 O
than 52 56 1327 1331 O
12 57 59 1332 1334 B-upper_bound
hours 60 65 1335 1340 I-upper_bound

Treated 0 7 1341 1348 O
with 8 12 1349 1353 O
an 13 15 1354 1356 O
investigational 16 31 1357 1372 B-clinical_variable
drug 32 36 1373 1377 I-clinical_variable
< 37 38 1378 1379 O
30 38 40 1379 1381 B-upper_bound
days 41 45 1382 1386 I-upper_bound
prior 46 51 1387 1392 I-upper_bound
to 52 54 1393 1395 O
Screening 55 64 1396 1405 O

Vitamin 0 7 1406 1413 B-treatment
K 8 9 1414 1415 I-treatment
antagonist 10 20 1416 1426 I-treatment
( 21 22 1427 1428 I-treatment
VKA 22 25 1428 1431 I-treatment
) 25 26 1431 1432 I-treatment

lactating 0 9 1433 1442 O
female 10 16 1443 1449 B-gender

minimally 0 9 1450 1459 O
invasive 10 18 1460 1468 B-treatment
surgery 19 26 1469 1476 I-treatment
/ 26 27 1476 1477 I-treatment
procedures 27 37 1477 1487 I-treatment

venous 0 6 1488 1494 B-chronic_disease
thromboembolism 7 22 1495 1510 I-chronic_disease
, 22 23 1510 1511 O
myocardial 24 34 1512 1522 B-chronic_disease
infarction 35 45 1523 1533 I-chronic_disease
, 45 46 1533 1534 O
disseminated 47 59 1535 1547 B-chronic_disease
intravascular 60 73 1548 1561 I-chronic_disease
coagulation 74 85 1562 1573 I-chronic_disease
( 86 87 1574 1575 I-chronic_disease
DIC 87 90 1575 1578 I-chronic_disease
) 90 91 1578 1579 I-chronic_disease
, 91 92 1579 1580 O
cerebral 93 101 1581 1589 O
vascular 102 110 1590 1598 O
accident 111 119 1599 1607 O
, 119 120 1607 1608 O
transient 121 130 1609 1618 B-chronic_disease
ischemic 131 139 1619 1627 I-chronic_disease
attack 140 146 1628 1634 I-chronic_disease
, 146 147 1634 1635 O
unstable 148 156 1636 1644 B-chronic_disease
angina 157 163 1645 1651 I-chronic_disease
pectoris 164 172 1652 1660 I-chronic_disease
hospitalization 173 188 1661 1676 O
or 189 191 1677 1679 O
severe 192 198 1680 1686 O
peripheral 199 209 1687 1697 B-chronic_disease
vascular 210 218 1698 1706 I-chronic_disease
disease 219 226 1707 1714 I-chronic_disease
within 227 233 1715 1721 O
2 234 235 1722 1723 B-upper_bound
weeks 236 241 1724 1729 I-upper_bound
prior 242 247 1730 1735 I-upper_bound
to 248 250 1736 1738 O
screening 251 260 1739 1748 O

